David H. Deming - 05 Feb 2026 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Director
Signature
/s/ Lisa C. Carson, Attorney-in-fact
Issuer symbol
PHIO
Transactions as of
05 Feb 2026
Net transactions value
$0
Form type
4
Filing time
06 Feb 2026, 07:59:20 UTC
Previous filing
15 Sep 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Deming David H Director C/O PHIO PHARMACEUTICALS CORP, 411 SWEDELAND RD., STE 23-1080, KING OF PRUSSIA /s/ Lisa C. Carson, Attorney-in-fact 06 Feb 2026 0001641063

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common Stock, $.0001 par value Award $0 +23,800 +170% $0.000000 37,800 05 Feb 2026 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying a restricted stock unit, which shares will vest on the first annual anniversary of the grant.
F2 Includes shares of common stock underlying unvested restricted stock units.